LATS1 and neoplasm: Within the Hippo pathway, MST1/2 and LATS1/2 act as tumor suppressors by inhibiting PD-L1 expression, whereas the downstream effectors YAP and TAZ promote PD-L1 upregulation, thereby impairing T-cell function and facilitating immune escape (155).